Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria

ClinicalTrials.gov ID: NCT03449199

Public ClinicalTrials.gov record NCT03449199. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 10, 2026, 5:01 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to assess the effect of 2 dose levels of TMX-049 on urinary albumin excretion in subjects with Type 2 diabetes and albuminuria (a urinary albumin-to-creatinine ratio (UACR) 200 to 3000 mg/g and an estimated glomerular filtration rate (eGFR) ≥30 ml/min/1.73m2). Effects of each TMX-049 dose on UACR will be assessed in terms of ratios using log-transformed UACR at Baseline and after a 12-week period of treatment.

Study identification

NCT ID
NCT03449199
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Teijin America, Inc.
Industry
Enrollment
130 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 9, 2018
Primary completion
May 6, 2019
Completion
Jun 3, 2019
Last update posted
Aug 29, 2022

2018 – 2019

United States locations

U.S. sites
55
U.S. states
23
U.S. cities
44
Facility City State ZIP Site status
AKDHC Medical Research Services, LLC Flagstaff Arizona 86001
Aventiv Research Inc. Mesa Arizona 85210
Comprehensive Research Institute Alhambra California 91801
California Kidney Specialists Covina California 91723
Torrance Clinical Research Institute, Inc. Lomita California 90717
Valley Clinical Trials, Inc. Northridge California 91325
Diabetes Associates Medical Group Orange California 92868
Desert Oasis Healthcare Medical Group Palm Springs California 92262
California Kidney Specialists San Dimas California 91773
North America Research Institute San Dimas California 91773
Leon Medical Research Miami Florida 33015
San Marcus Research Clinic, Inc. Miami Lakes Florida 33014
Endocrine Associates of Florida, P.A. Ocoee Florida 34761
Pines Care Research Center Pembroke Pines Florida 33026
Hanson Clinical Research Center Port Charlotte Florida 33952
Nephrology Associates, PC Augusta Georgia 30901
Southeastern Clinical Research Institute Augusta Georgia 30909
East-West Medical Research Institute Honolulu Hawaii 96814
Solaris Clinical Research, Llc Meridian Idaho 83646
Associate in Endocrinology Elgin Illinois 60124
Community Clinical Research Center Anderson Indiana 46011
Community Hospital of Anderson and Madison County, Inc. Anderson Indiana 46011
Iowa Kidney Physicians Des Moines Iowa 50265
Iowa Diabetes and Endocrinology Research Center West Des Moines Iowa 50265
My Kidney Center, LLC. Manhattan Kansas 66502
Cotton O'Neil Clinical Research Center Topeka Kansas 66606
Four Rivers Clincial Research Paducah Kentucky 42003
Ochsner Clinic Foundation, Baton Rouge Baton Rouge Louisiana 70809
Biolab Research LLC Rockville Maryland 20852
Aa Mrc Llc Flint Michigan 48504
Elite Research Center LLC Flint Michigan 48532
Endocrine Consultants of Mid Michigan Flint Michigan 48532
Seacost Kidney & Hypertension Specialists Portsmouth New Hampshire 03801
Albany Medical College, Division of Community Endocinology Albany New York 12206
Randolph Health Internal Medicine Asheboro North Carolina 27203
Carteret Medical Group Morehead City North Carolina 28557
PMG Research of Wilmington, LLC Wilmington North Carolina 28401
Brookview Hills Research Associates, LLC Winston-Salem North Carolina 27103
Synexus Clinical Research US, Inc. Centennial Health, PC Oklahoma City Oklahoma 73111
Detweiler Family Medicine & Associates, PC Lansdale Pennsylvania 19446
University Diabetes & Endocrine Consultants Chattanooga Tennessee 37411
Knoxville Kidney Center, PLLC Knoxville Tennessee 37923
Texas Health Physicians Group Dallas Texas 75243
The Medical Group of Texas Fort Worth Texas 76116
Rockwood Medical Clinic Fort Worth Texas 76164
Endocrine Associates Houston Texas 77004
Juno Research, LLC Houston Texas 77040
The Endocrine Center Houston Texas 77079
Pioneer Research Solutions INC Houston Texas 77099
Houston Nephrology Research Houston Texas 77429
Clinical Advancement Center, PLLC San Antonio Texas 78212
BFHC Research San Antonio Texas 78249
Carl R. Meisner Medical Clinic, PLLC Sugar Land Texas 77478
University of Utah School of Medicine Salt Lake City Utah 84108
Manassas Clinical Research Center Manassas Virginia 20110

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03449199, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 29, 2022 · Synced Sep 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03449199 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →